Association between Thrombocytopenia and Outcomes in Patients Undergoing Redo Valvular Surgery Utilizing Cardiopulmonary Bypass


  • Can Zhao Department of Cardiac Surgery, Peking University International Hospital, 102206 Beijing, China
  • Yaqiong Xiao Department of Cardiac Surgery, Peking University International Hospital, 102206 Beijing, China
  • Jianping Xu Department of Cardiac Surgery, Peking University International Hospital, 102206 Beijing, China



platelets, thrombocytopenia, redo valvular surgery, cardiopulmonary bypass, post-operation


Objective: To figure out the incidence of postoperative thrombocytopenia among adult cases undergoing redo valvular surgery with cardiopulmonary bypass (CPB) and to discern its ramifications on early postoperative outcomes. Methods: A cohort comprising 188 cases undergoing redo valvular surgery with CPB between March 2018 and July 2023 was analyzed. It was attempted to stratify cases into two groups on the basis of presence of thrombocytopenia that was defined as a nadir platelet count <71 × 103/μL within 72 hours (n = 45), or absence of thrombocytopenia (n = 143). Comparative evaluation was performed concerning postoperative mortality and morbidity. Logistic regression models were employed to unveil the relationship of thrombocytopenia with clinical outcomes. Results: Thrombocytopenia manifested in 45 (23.94%) cases. Univariate analysis disclosed a significant association of percent change in platelet count with mortality (odds ratio (OR), 1.039, 95% confidence interval (CI), 1.005 to 1.074, p = 0.024), postoperative pneumonia (OR, 1.058, 95% CI, 1.023 to 1.095, p = 0.001), prolonged mechanical ventilation (OR, 1.048, 95% CI, 1.026 to 1.071, p < 0.001), extended intensive care unit (ICU) stay (OR, 1.029, 95% CI, 1.010 to 1.049, p = 0.003), protracted post-operative hospitalization (OR, 1.031, 95% CI, 1.011 to 1.051, p = 0.002), postoperative renal replacement therapy (OR, 1.042, 95% CI, 1.017 to 1.069, p = 0.001), and re-thoracotomy attributable to hemorrhage (OR, 1.040, 95% CI, 1.000 to 1.080, p = 0.047). Multivariate analysis demonstrated that thrombocytopenia, regarded as a categorical variable, was independently correlated with an escalated likelihood of prolonged postoperative hospital stay (OR, 4.926, 95% CI, 1.740 to 13.948, p = 0.003). Conclusions: Thrombocytopenia appeared to be closely linked to escalated in-hospital mortality and postoperative morbidity rates among cases undergoing redo valvular surgery employing CPB. Further investigations with larger, prospective cohorts are essential to validate these outcomes and unravel potential underlying mechanisms.


Mandel J, Casari M, Stepanyan M, Martyanov A, Deppermann C. Beyond Hemostasis: Platelet Innate Immune Interactions and Thromboinflammation. International Journal of Molecular Sciences. 2022; 23: 3868.

Maouia A, Rebetz J, Kapur R, Semple JW. The Immune Nature of Platelets Revisited. Transfusion Medicine Reviews. 2020; 34: 209–220.

El Filaly H, Mabrouk M, Atifi F, Guessous F, Akarid K, Merhi Y, et al. Dissecting Platelet's Role in Viral Infection: A Double-Edged Effector of the Immune System. International Journal of Molecular Sciences. 2023; 24: 2009.

Hicks SM, Lee CSM, Ali SA, Choi PY, Gardiner EE. The molecular basis of immune-based platelet disorders. Clinical Science. 2020; 134: 2807–2822.

Squiccimarro E, Jiritano F, Serraino GF, Ten Cate H, Paparella D, Lorusso R. Quantitative and Qualitative Platelet Derangements in Cardiac Surgery and Extracorporeal Life Support. Journal of Clinical Medicine. 2021; 10: 615.

Hamid M, Akhtar MI, Naqvi HI, Ahsan K. Incidence and pattern of Thrombocytopenia in cardiac surgery patients. JPMA. the Journal of the Pakistan Medical Association. 2017; 67: 1019–1023.

Griffin BR, Bronsert M, Reece TB, Pal JD, Cleveland JC, Fullerton DA, et al. Thrombocytopenia After Cardiopulmonary Bypass Is Associated With Increased Morbidity and Mortality. The Annals of Thoracic Surgery. 2020; 110: 50–57.

Kertai MD, Zhou S, Karhausen JA, Cooter M, Jooste E, Li YJ, et al. Platelet Counts, Acute Kidney Injury, and Mortality after Coronary Artery Bypass Grafting Surgery. Anesthesiology. 2016; 124: 339–352.

Kilic A, Acker MA, Gleason TG, Sultan I, Vemulapalli S, Thibault D, et al. Clinical Outcomes of Mitral Valve Reoperations in the United States: An Analysis of The Society of Thoracic Surgeons National Database. The Annals of Thoracic Surgery. 2019; 107: 754–759.

Bianco V, Kilic A, Gleason TG, Aranda-Michel E, Habertheuer A, Wang Y, et al. Reoperative Cardiac Surgery Is a Risk Factor for Long-Term Mortality. The Annals of Thoracic Surgery. 2020; 110: 1235–1242.

Kim KM, Shannon F, Paone G, Lall S, Batra S, Boeve T, et al. Evolving trends in aortic valve replacement: A statewide experience. Journal of Cardiac Surgery. 2018; 33: 424–430.

Isaacs AJ, Shuhaiber J, Salemi A, Isom OW, Sedrakyan A. National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements. The Journal of Thoracic and Cardiovascular Surgery. 2015; 149: 1262–9.e3.

Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. American Journal of Infection Control. 2008; 36: 309–332.

Kizilay M, Elbir F, Aglar AA, Vural U, Balci AY, Yekeler İ. An overlooked fact: thrombocytopenia following bioprosthetic aortic valve replacement. Kardiochirurgia i Torakochirurgia Polska. 2019; 16: 19–26.

Di Dedda U, Ranucci M, Porta A, Bari V, Ascari A, Fantinato A, et al. The combined effects of the microcirculatory status and cardiopulmonary bypass on platelet count and function during cardiac surgery. Clinical Hemorheology and Microcirculation. 2018; 70: 327–337.

Argiriadou H, Antonitsis P, Gkiouliava A, Papapostolou E, Deliopoulos A, Anastasiadis K. Minimal invasive extracorporeal circulation preserves platelet function after cardiac surgery: a prospective observational study. Perfusion. 2020; 35: 138–144.

Mujtaba SS, Ledingham S, Shah AR, Schueler S, Clark S, Pillay T. Thrombocytopenia After Aortic Valve Replacement: Comparison Between Sutureless Perceval S Valve and Perimount Magna Ease Bioprosthesis. Brazilian Journal of Cardiovascular Surgery. 2018; 33: 169–175.

Xie E, Liu J, Liu Y, Liu Y, Xue L, Fan R, et al. Association between platelet counts and morbidity and mortality after endovascular repair for type B aortic dissection. Platelets. 2022; 33: 73–81.

van Straten AHM, Hamad MAS, Berreklouw E, ter Woorst JF, Martens EJ, Tan MESH. Thrombocytopenia after aortic valve replacement: comparison between mechanical and biological valves. The Journal of Heart Valve Disease. 2010; 19: 394–399.

Agarwal S, Johnson RI, Kirmani BH. Pre- and Post-Bypass Platelet Function Testing With Multiple Electrode Aggregometry and TEG Platelet Mapping in Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia. 2015; 29: 1272–1276.

Weitzel NS, Weitzel LB, Epperson LE, Karimpour-Ford A, Tran ZV, Seres T. Platelet mapping as part of modified thromboelastography (TEG®) in patients undergoing cardiac surgery and cardiopulmonary bypass. Anaesthesia. 2012; 67: 1158–1165.

Bønding Andreasen J, Hvas AM, Ravn HB. Marked changes in platelet count and function following pediatric congenital heart surgery. Paediatric Anaesthesia. 2014; 24: 386–392.

Selleng S, Malowsky B, Itterman T, Bagemühl J, Wessel A, Wollert HG, et al. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery. American Heart Journal. 2010; 160: 362–369.

Warkentin TE, Sheppard JI, Sun JCJ, Jung H, Eikelboom JW. Anti-PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis. Journal of Thrombosis and Haemostasis. 2013; 11: 253–260.

Pishko AM, Cuker A. Heparin-Induced Thrombocytopenia in Cardiac Surgery Patients. Seminars in Thrombosis and Hemostasis. 2017; 43: 691–698.

Deppermann C, Kubes P. Platelets and infection. Seminars in Immunology. 2016; 28: 536–545.

Thomas MR, Storey RF. The role of platelets in inflammation. Thrombosis and Haemostasis. 2015; 114: 449–458.

Yan S, Gao S, Lou S, Zhang Q, Wang Y, Ji B. Risk Factors of Thrombocytopenia After Cardiac Surgery with Cardiopulmonary Bypass. Brazilian Journal of Cardiovascular Surgery. 2023; 38: 389–397.

Zuchtriegel G, Uhl B, Puhr-Westerheide D, Pörnbacher M, Lauber K, Krombach F, et al. Platelets Guide Leukocytes to Their Sites of Extravasation. PLoS Biology. 2016; 14: e1002459.

Gleissner CA, von Hundelshausen P, Ley K. Platelet chemokines in vascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 2008; 28: 1920–1927.

Stokes KY, Granger DN. Platelets: a critical link between inflammation and microvascular dysfunction. The Journal of Physiology. 2012; 590: 1023–1034.

Jansen MPB, Florquin S, Roelofs JJTH. The role of platelets in acute kidney injury. Nature Reviews. Nephrology. 2018; 14: 457–471.

Ranucci M, Baryshnikova E, For The Surgical And Clinical Outcome Research Score Group. The interaction between preoperative platelet count and function and its relationship with postoperative bleeding in cardiac surgery. Platelets. 2017; 28: 794–798.

Ranucci M, Pistuddi V, Di Dedda U, Menicanti L, De Vincentiis C, Baryshnikova E. Platelet function after cardiac surgery and its association with severe postoperative bleeding: the PLATFORM study. Platelets. 2019; 30: 908–914.

Ichikawa J, Osada Y, Kodaka M, Nishiyama K, Komori M. Association Between Platelet Count and Postoperative Blood Loss in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass and Fresh Frozen Plasma Administration Guided by Thromboelastometry. Circulation Journal. 2018; 82: 677–683.



How to Cite

Zhao, C., Xiao, Y. ., & Xu, J. . (2024). Association between Thrombocytopenia and Outcomes in Patients Undergoing Redo Valvular Surgery Utilizing Cardiopulmonary Bypass. The Heart Surgery Forum, 27(6), E605-E612.